Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 109 entries
Sorted by: Best Match Show Resources per page
[Influence of the development of medicine on medical education].

Harefuah

Eliakim M.
PMID: 3817622
Harefuah. 1986 Nov 16;111(10):345-7.

No abstract available.

Cite
Eliakim M. [Influence of the development of medicine on medical education]. Harefuah. 1986;111(10):345-7
Eliakim, M. (1986). [Influence of the development of medicine on medical education]. Harefuah, 111(10), 345-7.
Eliakim, M. "[Influence of the development of medicine on medical education]." Harefuah vol. 111,10 (1986): 345-7.
Eliakim M. [Influence of the development of medicine on medical education]. Harefuah. 1986 Nov 16;111(10):345-7. Hebrew. PMID: 3817622.
Copy Download .nbib Format: NLM
[Hospital admission due to adverse drug reactions].

Harefuah

Eliakim M, Levy M.
PMID: 976851
Harefuah. 1976 Aug;91(3):98-9.

No abstract available.

Cite
Eliakim M, Levy M. [Hospital admission due to adverse drug reactions]. Harefuah. 1976;91(3):98-9
Eliakim, M., & Levy, M. (1976). [Hospital admission due to adverse drug reactions]. Harefuah, 91(3), 98-9.
Eliakim, M, and Levy, M. "[Hospital admission due to adverse drug reactions]." Harefuah vol. 91,3 (1976): 98-9.
Eliakim M, Levy M. [Hospital admission due to adverse drug reactions]. Harefuah. 1976 Aug;91(3):98-9. Hebrew. PMID: 976851.
Copy Download .nbib Format: NLM
Symptomatic retention of the patency capsule: a multicenter real life case series.

Endoscopy international open

Kopylov U, Nemeth A, Cebrian A, Wurm Johansson G, Thorlacius H, Fernandez-Urien Sainz I, Koulaouzidis A, Eliakim R, Toth E.
PMID: 27652302
Endosc Int Open. 2016 Sep;4(9):E964-9. doi: 10.1055/s-0042-112588. Epub 2016 Aug 08.

BACKGROUND AND AIMS: The patency capsule is designed to evaluate the patency of the small bowel before administration of small-bowel capsule endoscopy (SBCE) in patients at high risk of retention. The utilization of a patency capsule may be associated...

Cite
Kopylov U, Nemeth A, Cebrian A, et al. Symptomatic retention of the patency capsule: a multicenter real life case series. Endosc Int Open. 2016;4(9):E964-9doi: 10.1055/s-0042-112588.
Kopylov, U., Nemeth, A., Cebrian, A., Wurm Johansson, G., Thorlacius, H., Fernandez-Urien Sainz, I., Koulaouzidis, A., Eliakim, R., & Toth, E. (2016). Symptomatic retention of the patency capsule: a multicenter real life case series. Endoscopy international open, 4(9), E964-9. https://doi.org/10.1055/s-0042-112588
Kopylov, Uri, et al. "Symptomatic retention of the patency capsule: a multicenter real life case series." Endoscopy international open vol. 4,9 (2016): E964-9. doi: https://doi.org/10.1055/s-0042-112588
Kopylov U, Nemeth A, Cebrian A, Wurm Johansson G, Thorlacius H, Fernandez-Urien Sainz I, Koulaouzidis A, Eliakim R, Toth E. Symptomatic retention of the patency capsule: a multicenter real life case series. Endosc Int Open. 2016 Sep;4(9):E964-9. doi: 10.1055/s-0042-112588. Epub 2016 Aug 08. PMID: 27652302; PMCID: PMC5025315.
Copy Download .nbib Format: NLM
The impact of panenteric capsule endoscopy on the management of Crohn's disease.

Therapeutic advances in gastroenterology

Eliakim R.
PMID: 28932274
Therap Adv Gastroenterol. 2017 Sep;10(9):737-744. doi: 10.1177/1756283X17720860. Epub 2017 Jul 24.

Crohn's disease (CD) is a chronic inflammatory disease, in most patients involving the small and large bowel. In recent years, with the use of small bowel video capsule endoscopy (SBCE), it has become clear that in 50% or more...

Cite
Eliakim R. The impact of panenteric capsule endoscopy on the management of Crohn's disease. Therap Adv Gastroenterol. 2017;10(9):737-744doi: 10.1177/1756283X17720860.
Eliakim, R. (2017). The impact of panenteric capsule endoscopy on the management of Crohn's disease. Therapeutic advances in gastroenterology, 10(9), 737-744. https://doi.org/10.1177/1756283X17720860
Eliakim, Rami. "The impact of panenteric capsule endoscopy on the management of Crohn's disease." Therapeutic advances in gastroenterology vol. 10,9 (2017): 737-744. doi: https://doi.org/10.1177/1756283X17720860
Eliakim R. The impact of panenteric capsule endoscopy on the management of Crohn's disease. Therap Adv Gastroenterol. 2017 Sep;10(9):737-744. doi: 10.1177/1756283X17720860. Epub 2017 Jul 24. PMID: 28932274; PMCID: PMC5598809.
Copy Download .nbib Format: NLM
The Year That Was 2017: Highlights in Pediatric Exercise Research.

Pediatric exercise science

Falk B, Eliakim A.
PMID: 29417858
Pediatr Exerc Sci. 2018 Feb 01;30(1):11. doi: 10.1123/pes.2018-0016. Epub 2018 Feb 08.

No abstract available.

Cite
Falk B, Eliakim A. The Year That Was 2017: Highlights in Pediatric Exercise Research. Pediatr Exerc Sci. 2018;30(1):11doi: 10.1123/pes.2018-0016.
Falk, B., & Eliakim, A. (2018). The Year That Was 2017: Highlights in Pediatric Exercise Research. Pediatric exercise science, 30(1), 11. https://doi.org/10.1123/pes.2018-0016
Falk, Bareket, and Eliakim, Alon. "The Year That Was 2017: Highlights in Pediatric Exercise Research." Pediatric exercise science vol. 30,1 (2018): 11. doi: https://doi.org/10.1123/pes.2018-0016
Falk B, Eliakim A. The Year That Was 2017: Highlights in Pediatric Exercise Research. Pediatr Exerc Sci. 2018 Feb 01;30(1):11. doi: 10.1123/pes.2018-0016. Epub 2018 Feb 08. PMID: 29417858.
Copy Download .nbib Format: NLM
Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study.

Clinical epidemiology

Friedman MY, Leventer-Roberts M, Rosenblum J, Zigman N, Goren I, Mourad V, Lederman N, Cohen N, Matz E, Dushnitzky DZ, Borovsky N, Hoshen MB, Focht G, Avitzour M, Shachar Y, Chowers Y, Eliakim R, Ben-Horin S, Odes S, Schwartz D, Dotan I, Israeli E, Levi Z, Benchimol EI, Balicer RD, Turner D.
PMID: 29922093
Clin Epidemiol. 2018 Jun 07;10:671-681. doi: 10.2147/CLEP.S151339. eCollection 2018.

BACKGROUND: Before embarking on administrative research, validated case ascertainment algorithms must be developed. We aimed at developing algorithms for identifying inflammatory bowel disease (IBD) patients, date of disease onset, and IBD type (Crohn's disease [CD] vs ulcerative colitis [UC])...

Cite
Friedman MY, Leventer-Roberts M, Rosenblum J, et al. Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study. Clin Epidemiol. 2018;10:671-681doi: 10.2147/CLEP.S151339.
Friedman, M. Y., Leventer-Roberts, M., Rosenblum, J., Zigman, N., Goren, I., Mourad, V., Lederman, N., Cohen, N., Matz, E., Dushnitzky, D. Z., Borovsky, N., Hoshen, M. B., Focht, G., Avitzour, M., Shachar, Y., Chowers, Y., Eliakim, R., Ben-Horin, S., Odes, S., Schwartz, D., Dotan, I., Israeli, E., Levi, Z., Benchimol, E. I., Balicer, R. D., & Turner, D. (2018). Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study. Clinical epidemiology, 10671-681. https://doi.org/10.2147/CLEP.S151339
Friedman, Mira Y, et al. "Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study." Clinical epidemiology vol. 10 (2018): 671-681. doi: https://doi.org/10.2147/CLEP.S151339
Friedman MY, Leventer-Roberts M, Rosenblum J, Zigman N, Goren I, Mourad V, Lederman N, Cohen N, Matz E, Dushnitzky DZ, Borovsky N, Hoshen MB, Focht G, Avitzour M, Shachar Y, Chowers Y, Eliakim R, Ben-Horin S, Odes S, Schwartz D, Dotan I, Israeli E, Levi Z, Benchimol EI, Balicer RD, Turner D. Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study. Clin Epidemiol. 2018 Jun 07;10:671-681. doi: 10.2147/CLEP.S151339. eCollection 2018. PMID: 29922093; PMCID: PMC5995295.
Copy Download .nbib Format: NLM
Prostatic Abscess after Stapled Hemorrhoidopexy Caused by ESBL Extended Spectrum Beta Lactamase Producing .

Case reports in surgery

Saleh A, Kibeida A, Amin E, Khalil A, Abu Shakra R, Elwakil M.
PMID: 28798879
Case Rep Surg. 2017;2017:4154016. doi: 10.1155/2017/4154016. Epub 2017 Jul 17.

Postoperative septic complications of hemorrhoids surgical interventions are rare, but very serious with high mortality rate. Early diagnosis and prompt therapy are essential to save patient's life. There are a good number of articles and case reports about these...

Cite
Saleh A, Kibeida A, Amin E, et al. Prostatic Abscess after Stapled Hemorrhoidopexy Caused by ESBL Extended Spectrum Beta Lactamase Producing . Case Rep Surg. 2017;2017:4154016doi: 10.1155/2017/4154016.
Saleh, A., Kibeida, A., Amin, E., Khalil, A., Abu Shakra, R., & Elwakil, M. (2017). Prostatic Abscess after Stapled Hemorrhoidopexy Caused by ESBL Extended Spectrum Beta Lactamase Producing . Case reports in surgery, 20174154016. https://doi.org/10.1155/2017/4154016
Saleh, Asem, et al. "Prostatic Abscess after Stapled Hemorrhoidopexy Caused by ESBL Extended Spectrum Beta Lactamase Producing ." Case reports in surgery vol. 2017 (2017): 4154016. doi: https://doi.org/10.1155/2017/4154016
Saleh A, Kibeida A, Amin E, Khalil A, Abu Shakra R, Elwakil M. Prostatic Abscess after Stapled Hemorrhoidopexy Caused by ESBL Extended Spectrum Beta Lactamase Producing . Case Rep Surg. 2017;2017:4154016. doi: 10.1155/2017/4154016. Epub 2017 Jul 17. PMID: 28798879; PMCID: PMC5535695.
Copy Download .nbib Format: NLM
Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis.

Therapeutic advances in gastroenterology

Tham YS, Yung DE, Fay S, Yamamoto T, Ben-Horin S, Eliakim R, Koulaouzidis A, Kopylov U.
PMID: 30034529
Therap Adv Gastroenterol. 2018 Jul 08;11:1756284818785571. doi: 10.1177/1756284818785571. eCollection 2018.

BACKGROUND: Anastomotic recurrence is frequent in patients with Crohn's disease (CD) following ileocecal resection. The degree of endoscopic recurrence, quantified by the Rutgeerts score (RS), correlates with risk of clinical and surgical recurrence. Several studies demonstrate the accuracy of...

Cite
Tham YS, Yung DE, Fay S, et al. Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis. Therap Adv Gastroenterol. 2018;11:1756284818785571doi: 10.1177/1756284818785571.
Tham, Y. S., Yung, D. E., Fay, S., Yamamoto, T., Ben-Horin, S., Eliakim, R., Koulaouzidis, A., & Kopylov, U. (2018). Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis. Therapeutic advances in gastroenterology, 111756284818785571. https://doi.org/10.1177/1756284818785571
Tham, Yuen Sau, et al. "Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis." Therapeutic advances in gastroenterology vol. 11 (2018): 1756284818785571. doi: https://doi.org/10.1177/1756284818785571
Tham YS, Yung DE, Fay S, Yamamoto T, Ben-Horin S, Eliakim R, Koulaouzidis A, Kopylov U. Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis. Therap Adv Gastroenterol. 2018 Jul 08;11:1756284818785571. doi: 10.1177/1756284818785571. eCollection 2018. PMID: 30034529; PMCID: PMC6048608.
Copy Download .nbib Format: NLM
Carbon stocks for different land cover types in Mainland Tanzania.

Carbon balance and management

Mauya EW, Mugasha WA, Njana MA, Zahabu E, Malimbwi R.
PMID: 31030302
Carbon Balance Manag. 2019 Apr 27;14(1):4. doi: 10.1186/s13021-019-0120-1.

BACKGROUND: Developing countries participating in the mitigation mechanism of reducing emissions from deforestation and forest degradation (REDD+), are required to establish a forest reference emission level (FREL), if they wish to seek financial support to reduce carbon emissions from...

Cite
Mauya EW, Mugasha WA, Njana MA, et al. Carbon stocks for different land cover types in Mainland Tanzania. Carbon Balance Manag. 2019;14(1):4doi: 10.1186/s13021-019-0120-1.
Mauya, E. W., Mugasha, W. A., Njana, M. A., Zahabu, E., & Malimbwi, R. (2019). Carbon stocks for different land cover types in Mainland Tanzania. Carbon balance and management, 14(1), 4. https://doi.org/10.1186/s13021-019-0120-1
Mauya, Ernest William, et al. "Carbon stocks for different land cover types in Mainland Tanzania." Carbon balance and management vol. 14,1 (2019): 4. doi: https://doi.org/10.1186/s13021-019-0120-1
Mauya EW, Mugasha WA, Njana MA, Zahabu E, Malimbwi R. Carbon stocks for different land cover types in Mainland Tanzania. Carbon Balance Manag. 2019 Apr 27;14(1):4. doi: 10.1186/s13021-019-0120-1. PMID: 31030302; PMCID: PMC7227115.
Copy Download .nbib Format: NLM
Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?.

Therapeutic advances in gastroenterology

Mao R, Tang RH, Qiu Y, Chen BL, Guo J, Zhang SH, Li XH, Feng R, He Y, Li ZP, Zeng ZR, Eliakim R, Ben-Horin S, Chen MH.
PMID: 29899757
Therap Adv Gastroenterol. 2018 Jun 05;11:1756284818777938. doi: 10.1177/1756284818777938. eCollection 2018.

BACKGROUND: The Montreal classification defines L4 Crohn's disease (CD) as any disease location proximal to the terminal ileum, which anatomically includes L4-esophagogastroduodenal (EGD), L4-jejunal, and L4-proximal ileal involvement. L4-jejunal disease was established to be associated with poor prognosis. However,...

Cite
Mao R, Tang RH, Qiu Y, et al. Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?. Therap Adv Gastroenterol. 2018;11:1756284818777938doi: 10.1177/1756284818777938.
Mao, R., Tang, R. H., Qiu, Y., Chen, B. L., Guo, J., Zhang, S. H., Li, X. H., Feng, R., He, Y., Li, Z. P., Zeng, Z. R., Eliakim, R., Ben-Horin, S., & Chen, M. H. (2018). Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?. Therapeutic advances in gastroenterology, 111756284818777938. https://doi.org/10.1177/1756284818777938
Mao, Ren, et al. "Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?." Therapeutic advances in gastroenterology vol. 11 (2018): 1756284818777938. doi: https://doi.org/10.1177/1756284818777938
Mao R, Tang RH, Qiu Y, Chen BL, Guo J, Zhang SH, Li XH, Feng R, He Y, Li ZP, Zeng ZR, Eliakim R, Ben-Horin S, Chen MH. Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?. Therap Adv Gastroenterol. 2018 Jun 05;11:1756284818777938. doi: 10.1177/1756284818777938. eCollection 2018. PMID: 29899757; PMCID: PMC5990878.
Copy Download .nbib Format: NLM
[No title available]

Tropical medicine and health

Paul E, Kiwelu I, Mmbaga B, Nazareth R, Sabuni E, Maro A, Ndaro A, Halliday JEB, Chilongola J.
PMID: 30479556
Trop Med Health. 2018 Nov 19;46:39. doi: 10.1186/s41182-018-0122-9. eCollection 2018.

BACKGROUND: Acute METHODS: A hospital-based cross-sectional study was carried out from 1 February to 30 April 2017. Data on maternal demographic characteristics, obstetric history, knowledge, and practices related to RESULTS: The overall CONCLUSION: Based on serology results, we report...

Cite
Paul E, Kiwelu I, Mmbaga B, et al. . Trop Med Health. 2018;46:39doi: 10.1186/s41182-018-0122-9.
Paul, E., Kiwelu, I., Mmbaga, B., Nazareth, R., Sabuni, E., Maro, A., Ndaro, A., Halliday, J. E. B., & Chilongola, J. (2018). . Tropical medicine and health, 4639. https://doi.org/10.1186/s41182-018-0122-9
Paul, Eliakimu, et al. "." Tropical medicine and health vol. 46 (2018): 39. doi: https://doi.org/10.1186/s41182-018-0122-9
Paul E, Kiwelu I, Mmbaga B, Nazareth R, Sabuni E, Maro A, Ndaro A, Halliday JEB, Chilongola J. . Trop Med Health. 2018 Nov 19;46:39. doi: 10.1186/s41182-018-0122-9. eCollection 2018. PMID: 30479556; PMCID: PMC6245905.
Copy Download .nbib Format: NLM
Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus.

Eye and vision (London, England)

Kirgiz A, Eliacik M, Yildirim Y.
PMID: 31172016
Eye Vis (Lond). 2019 Jun 03;6:16. doi: 10.1186/s40662-019-0141-6. eCollection 2019.

BACKGROUND: To compare the outcomes of two different protocols of accelerated corneal crosslinking (CXL) on visual, corneal high order aberrations (HOA) and topographic parameters in patients with progressive keratoconus.METHODS: In this prospective comparative study, sixty-six eyes of 66 patients...

Cite
Kirgiz A, Eliacik M, Yildirim Y. Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus. Eye Vis (Lond). 2019;6:16doi: 10.1186/s40662-019-0141-6.
Kirgiz, A., Eliacik, M., & Yildirim, Y. (2019). Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus. Eye and vision (London, England), 616. https://doi.org/10.1186/s40662-019-0141-6
Kirgiz, Ahmet, et al. "Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus." Eye and vision (London, England) vol. 6 (2019): 16. doi: https://doi.org/10.1186/s40662-019-0141-6
Kirgiz A, Eliacik M, Yildirim Y. Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus. Eye Vis (Lond). 2019 Jun 03;6:16. doi: 10.1186/s40662-019-0141-6. eCollection 2019. PMID: 31172016; PMCID: PMC6545739.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 109 entries